0001209191-15-008474.txt : 20150202 0001209191-15-008474.hdr.sgml : 20150202 20150202210258 ACCESSION NUMBER: 0001209191-15-008474 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150129 FILED AS OF DATE: 20150202 DATE AS OF CHANGE: 20150202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MYLAN INC. CENTRAL INDEX KEY: 0000069499 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 251211621 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 MYLAN BOULEVARD CITY: CANONSBURG STATE: PA ZIP: 15317 BUSINESS PHONE: 724-514-1800 MAIL ADDRESS: STREET 1: 1000 MYLAN BOULEVARD CITY: CANONSBURG STATE: PA ZIP: 15317 FORMER COMPANY: FORMER CONFORMED NAME: MYLAN LABORATORIES INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: FRM CORP DATE OF NAME CHANGE: 19711003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: COURY ROBERT J CENTRAL INDEX KEY: 0001197543 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09114 FILM NUMBER: 15568974 MAIL ADDRESS: STREET 1: 1500 CORPORATE DRIVE STREET 2: SUITE 400 CITY: CANONSBURG STATE: PA ZIP: 15317 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-01-29 0 0000069499 MYLAN INC. MYL 0001197543 COURY ROBERT J 1000 MYLAN BLVD CANONSBURG PA 15317 1 1 0 0 Executive Chairman Common Stock 2015-01-29 4 M 0 71438 0.00 A 1123077 D Common Stock 2015-01-29 4 A 0 263666 0.00 A 1386743 D Common Stock 2015-01-29 4 F 0 161037 54.885 D 1225706 D Common Stock 2015-01-29 4 M 0 86251 23.44 A 1311957 D Common Stock 2015-01-29 4 M 0 99768 30.90 A 1411725 D Common Stock 2015-01-29 4 F 0 135035 54.885 D 1276690 D Common Stock 4957 I By 401(k) Plan Restricted Stock Units 0.00 2015-01-29 4 M 0 71438 0.00 D 2015-01-29 Common Stock 71438 0 D Employee Stock Option - Right to Buy 23.44 2015-01-29 4 M 0 86251 0.00 D 2015-01-29 2022-02-22 Common Stock 86251 185301 D Employee Stock Option - Right to Buy 30.90 2015-01-29 4 M 0 99768 0.00 D 2015-01-29 2023-03-06 Common Stock 99768 54738 D Represents acquisition of shares of Mylan common stock upon vesting of RSUs. Represents acquisition of shares of Mylan common stock upon vesting of PRSUs. Each PRSU represents the right to receive shares of Mylan common stock. The PRSUs were granted on February 22, 2012, March 6, 2013 and March 5, 2014. Represents withholding of shares of Mylan common stock for the tax liability associated with the vesting of RSUs and PRSUs. Represents acquisition of Mylan common stock upon exercise of stock options granted on February 22, 2012. Represents acquisition of Mylan common stock upon exercise of stock options granted on March 6, 2013. Represents withholding of shares of Mylan common stock to satisfy the exercise price and tax liability associated with the exercise of stock options granted on February 22, 2012 and March 6, 2013. Each RSU represents the right to receive one share of Mylan common stock. The RSUs were granted on February 22, 2012, March 6, 2013 and March 5, 2014. The transactions described on this Form 4 are described in the proxy statement filed by Mylan Inc. ("Mylan") on December 24, 2014 and the Form 8-K filed by Mylan on November 5, 2014. In connection with the proposed acquisition (the "Transaction") by a new public company organized in the Netherlands of both Mylan and Abbott Laboratories' non-U.S. developed markets specialty and branded generics business, Mylan's Board of Directors determined, effective November 4, 2014, that the vesting of all unvested stock options, restricted stock units ("RSUs"), and performance restricted stock units ("PRSUs") granted to directors and executive officers as part of Mylan's ordinary course annual equity compensation program (other than incentive stock options and the options granted in 2014) would be accelerated prior to the Transaction. /s/ Bradley L. Wideman, by power of attorney 2015-02-02